MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Connectivity matrices for differentiating voluntary stopping states and involuntary freezing states in Parkinson’s disease

    D. Salgado, A. Pineda, C. Alves, R. Carra, F. Rodrigues, M. Souza, R. Cury (São Paulo, Brazil)

    Objective: The present study aims to demonstrate a possible application of the analysis of functional brain connectivity from brain connectivity matrices. Specifically, we aim to: - Differentiate…
  • 2022 International Congress

    Studying Care Patterns and Support Preferences Among People Living with Parkinson’s Disease

    C. Pearson, M. Feeney, A. Willis, N. Yarab, R. Dolhun, V. Todaro, S. Rosenfeld (Chicago, USA)

    Objective: To understand health care utilization among Medicare beneficiaries living with Parkinson’s Disease (PD) and how care patterns differ across demographic groups. Background: Optimal care…
  • 2022 International Congress

    Satisfaction level: quality of life, motor and non-motor symptoms outcomes of Mexican PD patients after deep brain stimulation.

    P. Bazán-Rodríguez, E. Reséndiz-Henríquez, E. Ichikawa-Escamilla, AJ. Hernández-Medrano, GI. Cerda-Hernández, MA. Ruiz-Mafud, L. Bazán-Rodríguez, C. Martínez-Cortés, RA. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To evaluate satisfaction level and quality of life in Mexican PD patients after undergoing deep brain stimulation surgery using a structured questionnaire assessimg motor…
  • 2022 International Congress

    The Edmond J. Safra Fellowship in Movement Disorders: A Global Network of Parkinson’s Experts

    R. Dolhun (New York, USA)

    Objective: To train more movement disorder clinician-researchers around the world to meet growing care and research needs in Parkinson’s and related disorders. Background: Care from…
  • 2022 International Congress

    Impact of ApoE genotype on cognition in idiopathic and genetic forms of Parkinson’s disease

    C. Koros, K. Brockmann, Aμ. Simitsi, A. Bougea, H. Liu, ακ. Hauser, C. Schulte, I. Pachi, N. Papagiannakis, A. Zahou, I. Wurster, E. Efthymiopoulou, I. Beratis, R. Antonelou, M. Maniati, M. Moraitou, H. Michelakakis, G. Paraskevas, S. Papageorgiou, C. Potagas, D. Papadimitriou, M. Bozi, M. Stamelou, T. Gasser, L. Stefanis (Athens, Greece)

    Objective: The aim of our current report was to assess the impact of Apolipoprotein-E (ApoE) genotype on cognition in idiopathic Parkinson’s disease (PD) patients and…
  • 2022 International Congress

    Cognitive performance and learning parameters predict response to working memory training in Parkinson’s disease

    A. Ophey, J. Wenzel, R. Paul, K. Giehl, C. Eggers, P. Reker, T. van Eimeren, E. Kalbe, L. Kambeitz-Ilankovic (Cologne, Germany)

    Objective: The present study aims to evaluate a multivariable model to predict verbal working memory (WM) performance following a targeted cognitive training intervention, WM training…
  • 2022 International Congress

    May apomorphine be helpful for the axial symptoms of Parkinson’s Disease?

    A. Alonso-Canovas, P. Perez Torre, G. Sanchez Diez, A. Patiño Paton, N. Gonzalez, I. Parees Moreno, JC. Martinez Castrillo (Madrid, Spain)

    Objective: To assess the effect of continuous subcutaneous infusion of apomorphine on axial symptoms of Parkinson Disease. Background: Axial symptoms of Parkinson’s Disease may be…
  • 2022 International Congress

    Cognitive Function in Late-life and Parkinson’s Disease Neuropathology at Death

    R. Abbott, G. Ross, H. Petrovitch, K. Masaki, J. Uyehara-Lock, C. Tanner (Ansan-si, Republic of Korea)

    Objective: To examine the association between cognitive function in late-life and Parkinson’s disease (PD) neuropathology at death, including 1) neuron loss in the locus coeruleus…
  • 2022 International Congress

    Demographic and Regional Variation in All-Cause Mortality Rates among United States Medicare Beneficiaries with Parkinson’s Disease

    W. Aamodt, A. Willis, J. Farrar (Philadelphia, USA)

    Objective: To determine whether all-cause mortality rates among persons with Parkinson’s disease (PD) in the United States (US) differ by sex, race/ethnicity, or geographic location.…
  • 2022 International Congress

    Newly identified cases of parkinsonism and prodromal PD in a remote LRRK2 G2019S cohort

    J. Soto, S. Jensen-Roberts, T. Myers, M. Pawlik, E. Hartman, S. Lettenberger, A. Kaplan, R. Toor, R. Wilson, P. Auinger, E. Dorsey, B. Valdovinos, K. Amodeo, S. Sharma, R. Holloway, C. Tanner, R. Alcalay, R. Schneider (Rochester, USA)

    Objective: To evaluate new cases of prodromal PD and concern for parkinsonism in a cohort of LRRK2 G2019S carriers. Background: LRRK2 G2019S is a common…
  • « Previous Page
  • 1
  • …
  • 318
  • 319
  • 320
  • 321
  • 322
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley